BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36177738)

  • 1. Ivermectin treatment in rosacea: How novel smartphone technology can support monitoring rosacea-associated signs and symptoms.
    Schaller M; Riel S; Bashur R; Kurup N; Schnidar H; Fehrenbacher B
    Dermatol Ther; 2022 Nov; 35(11):e15869. PubMed ID: 36177738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea.
    Schaller M; Gonser L; Belge K; Braunsdorf C; Nordin R; Scheu A; Borelli C
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1907-1911. PubMed ID: 28653460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol.
    Huang HP; Hsu CK; Lee JY
    Dermatol Ther; 2021 Mar; 34(2):e14899. PubMed ID: 33605018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea.
    Schaller M; Kemény L; Havlickova B; Jackson JM; Ambroziak M; Lynde C; Gooderham M; Remenyik E; Del Rosso J; Weglowska J; Chavda R; Kerrouche N; Dirschka T; Johnson S
    J Am Acad Dermatol; 2020 Feb; 82(2):336-343. PubMed ID: 31150711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised, split-face study of a dermocosmetic cream containing Sphingobioma xenophaga extract and Neurosensine
    Berardesca E; Cartigliani C; Nioré M; Bonfigli A; Canchy L; Kerob D; Tan J
    Skin Res Technol; 2024 Jun; 30(6):e13735. PubMed ID: 38899754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema-directed digital photography and colorimeter scores correlate with rosacea erythema evaluation in patients under treatment with topical ivermectin.
    Dall'Oglio F; Lacarrubba F; Micali G
    Dermatol Ther; 2021 May; 34(3):e14920. PubMed ID: 33641260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study.
    Eichenfield LF; Del Rosso JQ; Tan JKL; Hebert AA; Webster GF; Harper J; Baldwin HE; Kircik LH; Stein-Gold L; Kaoukhov A; Alvandi N
    Br J Dermatol; 2019 May; 180(5):1050-1057. PubMed ID: 30500065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety results of micellar water, cream and serum for rosacea in comparison to a control group.
    Guertler A; Jøntvedt NM; Clanner-Engelshofen BM; Cappello C; Sager A; Reinholz M
    J Cosmet Dermatol; 2020 Oct; 19(10):2627-2633. PubMed ID: 32623833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.
    Draelos ZD; Gold MH; Weiss RA; Baumann L; Grekin SK; Robinson DM; Kempers SE; Alvandi N; Weng E; Berk DR; Ahluwalia G
    J Am Acad Dermatol; 2018 Jun; 78(6):1156-1163. PubMed ID: 29409914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin: A Review in Rosacea.
    Deeks ED
    Am J Clin Dermatol; 2015 Oct; 16(5):447-52. PubMed ID: 26254001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
    Baumann L; Goldberg DJ; Stein Gold L; Tanghetti EA; Lain E; Kaufman J; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Mar; 17(3):290-298. PubMed ID: 29537447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Topical Ivermectin for the Treatment of Cutaneous and Ocular Rosacea.
    Sobolewska B; Doycheva D; Deuter CM; Schaller M; Zierhut M
    Ocul Immunol Inflamm; 2021 Aug; 29(6):1137-1141. PubMed ID: 32255398
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of a simple image-based tool to quantify facial erythema in rosacea during treatment.
    Logger JGM; de Jong EMGJ; Driessen RJB; van Erp PEJ
    Skin Res Technol; 2020 Nov; 26(6):804-812. PubMed ID: 32537843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and safety of Oxymetazoline cream 1% on rosacea-associated erythema: A systematic review and analysis of clinical evidence.
    Yuan X; Yin D
    J Cosmet Dermatol; 2023 Jan; 22(1):103-110. PubMed ID: 36237138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.
    Tanghetti EA; Dover JS; Goldberg DJ; Dhawan SS; Luo L; Berk DR; Ahluwalia G; Alvandi N
    J Drugs Dermatol; 2018 Jun; 17(6):621-626. PubMed ID: 29879249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin compatibility and efficacy of a cosmetic skin care regimen with licochalcone A and 4-t-butylcyclohexanol in patients with rosacea subtype I.
    Schoelermann AM; Weber TM; Arrowitz C; Rizer RL; Qian K; Babcock M
    J Eur Acad Dermatol Venereol; 2016 Feb; 30 Suppl 1():21-7. PubMed ID: 26805419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facial Dermatitis and Rosacea.
    Fowler JF
    Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S107-9. PubMed ID: 27537212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and erythema-directed imaging evaluation of papulo-pustular rosacea with topical ivermectin: a 32 weeks duration study.
    Dall'Oglio F; Lacarrubba F; Luca M; Boscaglia S; Micali G
    J Dermatolog Treat; 2019 Nov; 30(7):703-707. PubMed ID: 30663445
    [No Abstract]   [Full Text] [Related]  

  • 19. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.
    Dahl MV; Jarratt M; Kaplan D; Tuley MR; Baker MD
    J Am Acad Dermatol; 2001 Nov; 45(5):723-30. PubMed ID: 11606923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication and efficacy assessment of combination of brimonidine and ivermectin for treatment of papulopustular rosacea.
    Pakdaman SF; Samadi A; Fattahi M; Naeimifar A; Ardehali FA; Ketabi Y; Nasrollahi SA; Firooz A
    J Cosmet Dermatol; 2024 Jun; ():. PubMed ID: 38831548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.